Gene · 5277
Papers1,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breakthrough Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: Mechanistic Insights and Management Strategies. | Transfusion | 2026 | 42755219 | PubTator, text mining | PubMed |
| Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy. | Leukemia | 2026 | 42693160 | PubTator, text mining | PubMed |
| A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG. | PLoS Genet | 2026 | 42672098 | PubTator, text mining | PubMed |
| Does the 2-test in vitro genotoxicity battery of Ames plus in vitro micronucleus tests detect relevant substances that induce gene mutations in vivo? | Mutat Res Genet Toxicol Environ Mutagen | 2026 | 42580787 | PubTator, text mining | PubMed |
| Haemolytic Anaemia; Beyond Sickle Cell Anaemia: A Case Series of Patients With Paroxysmal Nocturnal Haemoglobinuria in Kenya. | Case Rep Hematol | 2026 | 42529569 | PubTator, text mining | PubMed |
| Investigation of Ethylene Oxide Genotoxicity Dose-Response to Inform Cancer Risk Assessment. | Environ Mol Mutagen | 2026 | 42454540 | PubTator, text mining | PubMed |
| Concurrent Loss of PIGA and ZRSR2 in a Patient With Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Neoplasm. | Int J Lab Hematol | 2026 | 42432858 | PubTator, text mining | PubMed |
| Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia. | NEJM Evid | 2026 | 42047559 | PubTator, text mining | PubMed |
| A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG. | bioRxiv | 2026 | 42039650 | PubTator, text mining | PubMed |
| Imputing causality and clonal dynamics from single-cell transcriptomics in paroxysmal nocturnal hemoglobinuria. | Leukemia | 2026 | 42020783 | PubTator, text mining | PubMed |
| Developmental and epileptic encephalopathies with germline PIGA variants in five Chinese children: a case report and literature review. | Front Genet | 2026 | 41970642 | PubTator, text mining | PubMed |
| Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment. | J Comp Eff Res | 2026 | 41852168 | PubTator, text mining | PubMed |
| Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. | J Blood Med | 2026 | 41809517 | PubTator, text mining | PubMed |
| Biomarkers of Coagulation Disorders-Where to from Here? | Biomolecules | 2026 | 41750305 | PubTator, text mining | PubMed |
| Myoclonus in Pediatric Metabolic Diseases: Clinical Spectrum, Mechanisms, and Treatable Causes-A Systematic Review. | Metabolites | 2026 | 41745581 | PubTator, text mining | PubMed |
| The "Immune Rebellion" from the Intestines to the Liver: A Vicious Cycle That Causes the Liver to Collapse. | Metabolites | 2026 | 41745575 | PubTator, text mining | PubMed |
| Clinical Profile, Humanistic and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria in Patients Treated With C5 Inhibitors. | EJHaem | 2026 | 41716293 | PubTator, text mining | PubMed |
| Clonal expansion mechanisms in paroxysmal nocturnal hemoglobinuria. | Int J Hematol | 2026 | 41656394 | PubTator, text mining | PubMed |
| Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML. | Exp Hematol Oncol | 2026 | 41634865 | PubTator, text mining | PubMed |
| Integrative miRNA-mRNA Network and Molecular Dynamics-Based Identification of Therapeutic Candidates for Paroxysmal Nocturnal Hemoglobinuria. | Pharmaceuticals (Basel) | 2026 | 41599741 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5277/papers